Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Inturrisi

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|June 14, 2013
Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like actionJin Xu, Ming Xu, Taylor Brown, et al.
Neuroscience Letters|November 3, 2009
Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preferenceAnn M Gregus, Thomas F Tropea, Yanran Wang, et al.
Hormones and Behavior|November 1, 2005
Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female ratsTzipora Kuba, Hui-Bing K Wu, Arbi Nazarian, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and GentamicinEzio Bettini, Sara De Martin, Andrea Mattarei, et al.
Synapse (New York, N.Y.)|December 7, 2010
Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activationDeirtra A Hunter, Gordon A Barr, Nicole Amador, et al.
Drugs in R&D|November 27, 2023
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated MetabolismNicola Ferri, Sara De Martin, James Stuart, et al.
Drugs in R&D|August 2, 2024
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic ImpairmentNicola Ferri, Sara De Martin, James Stuart, et al.
Frontiers in Pharmacology|May 17, 2021
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical StudySara De Martin, Daniela Gabbia, Franco Folli, et al.
Molecular Psychiatry|May 28, 2024
Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'Marco Pappagallo, Thomas R Kosten, Charles W Gorodetzky, et al.
The Journal of Pain|November 21, 2017
Patient-Reported Outcomes and Opioid Use by Outpatient Cancer PatientsNatalie Moryl, Vinnidhy Dave, Paul Glare, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|June 14, 2013
Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like actionJin Xu, Ming Xu, Taylor Brown, et al.
Neuroscience Letters|November 3, 2009
Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preferenceAnn M Gregus, Thomas F Tropea, Yanran Wang, et al.
Hormones and Behavior|November 1, 2005
Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female ratsTzipora Kuba, Hui-Bing K Wu, Arbi Nazarian, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and GentamicinEzio Bettini, Sara De Martin, Andrea Mattarei, et al.
Synapse (New York, N.Y.)|December 7, 2010
Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activationDeirtra A Hunter, Gordon A Barr, Nicole Amador, et al.
Drugs in R&D|November 27, 2023
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated MetabolismNicola Ferri, Sara De Martin, James Stuart, et al.
Drugs in R&D|August 2, 2024
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic ImpairmentNicola Ferri, Sara De Martin, James Stuart, et al.
Frontiers in Pharmacology|May 17, 2021
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical StudySara De Martin, Daniela Gabbia, Franco Folli, et al.
Molecular Psychiatry|May 28, 2024
Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'Marco Pappagallo, Thomas R Kosten, Charles W Gorodetzky, et al.
The Journal of Pain|November 21, 2017
Patient-Reported Outcomes and Opioid Use by Outpatient Cancer PatientsNatalie Moryl, Vinnidhy Dave, Paul Glare, et al.
Pageof 7